National Comprehensive Cancer Network NCCN

CMS Officially Recognizes NCCN Drugs & Biologics Compendium

Published in Hospital Business Week, June 22nd, 2008

NCCN is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) has recognized the NCCN Drugs & Biologics Compendium(TM) as a mandated reference for establishment of coverage policy and coverage decisions regarding the use of drugs and biologics in cancer care.

The NCCN Compendium will be used by CMS for national coverage determinations and by intermediaries and carriers for locoregional determinations. The major application will be in determinations about coverage for the use of drugs and biologics in oncology beyond the FDA approved indication.

This recognition comes on the heels of a recent announcement that UnitedHealthcare...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Business Week

Source: Hospital Business Week (2008-06-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry